Deputy FDA chief mulls shak­ing up PDU­FA reau­tho­riza­tion struc­ture

The FDA is prep­ping to rene­go­ti­ate its multi­bil­lion-dol­lar, quin­quen­ni­al user fee agree­ments with the drug in­dus­try lat­er this sum­mer, and a new deputy com­mis­sion­er on …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER